NCT04711304View on ClinicalTrials.gov

Evaluation of Safety and Efficacy of Wharton's Jelly Compared to Hyaluronic Acid and Saline for Knee Osteoarthritis.

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Osteoarthritis, Knee
Interventions
BIOLOGICAL

Umbilical Cord-derived Wharton's Jelly

Intraarticular injection

DEVICE

Hyaluronic acid

Intraarticular injection

OTHER

Saline

Intraarticular injection

Sponsors

Lead Sponsor

BioIntegrate
All Listed Sponsors
lead

BioIntegrate

INDUSTRY